Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 96INDUSTRY 14NIH 8NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 159Other hematologic neoplasm 53Sarcoma 22CNS 14Dermatologic 13Myeloid 8Plasma cell 7Other neoplasm 6Gynecologic 6Gastrointestinal 5Genitourinary 4Head & Neck 3Thoracic 2Other solid neoplasm 2Breast 2Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 10Myelodysplastic Syndromes 8Leukemia 7Leukemia, Myelomonocytic, Chronic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Anemia, Refractory 5Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Anemia 3Thrombocytopenia 2Neutropenia 2Neoplasms 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Hodgkin Disease 2Congenital Abnormalities 2Anemia, Sickle Cell 2Anemia, Aplastic 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Tourette Syndrome 1Testicular Neoplasms 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1

Interventions

Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma × Classical hematology × Clear all
NCT06859424 2026-03-17

ACCELERATE

Center for International Blood and Marrow Transplant Research

Phase 2 Recruiting
358 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Lymphoma, Myeloproliferative Disorders, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡